Spots Global Cancer Trial Database for Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia
Official Title: Pharmacogenomic Analysis of 6-mercaptopurine in Pediatric Acute Lymphoblastic Leukemia
Study ID: NCT04770922
Interventions
Study Description
Brief Summary: This is a retrospective biobank study evaluating the impact of novel genetic variants in a population of 6-mercaptopurine treated pediatric acute lymphoblastic leukemia patients.
Detailed Description: The study objective is to clinically validate that the presence of recently discovered novel genetic variation adversely affects a population of 6-mercaptopurine treated pediatric acute lymphoblastic leukemia patients using biobank samples.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stanford University, Stanford, California, United States
Contact Details
Name: Kathleen M Sakamoto, MD, PhD
Affiliation: Stanford University
Role: PRINCIPAL_INVESTIGATOR
Name: Stephanie M Smith, MD
Affiliation: Stanford University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
